[Comparative analyses on osteoporosis guidelines in Japan, EU and USA].
Ishii
Jun
J
Saitama Medical School.
D019386:Alendronate; D002116:Calcitonin; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004964:Estriol; D012968:Etidronic Acid; D005060:Europe; D006801:Humans; D007529:Isoflavones; D007564:Japan; D010024:Osteoporosis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D020849:Raloxifene Hydrochloride; D014481:United States; D024482:Vitamin K 2 / Q000031:analogs & derivatives*
D007529:Isoflavones; D024482:Vitamin K 2; C030814:menatetrenone; D020849:Raloxifene Hydrochloride; C018986:ipriflavone; D002116:Calcitonin; D004964:Estriol; D012968:Etidronic Acid; D019386:Alendronate